Search
for
Sort by
Research 241–270 of 1000+
- Older age and low testosterone levels are independently associated with kidney stone prevalence in men: results from a large cross-sectional study
- Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Cancer-Related Alopecia Risk and Treatment
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views
- Global research trends in non-muscle invasive bladder cancer: Bibliometric and visualized analysis
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Advancing Design Strategy of PROTACs for Cancer Therapy
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Signal integrator function of CXXC5 in Cancer
- ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer
- Development and validation of an UPLC method for determination of content uniformity in low-dose solid drugs products using the design space approach
- The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Glibenclamide inhibits cell growth by inducing G0/G1 arrest in the human breast cancer cell line MDA-MB-231
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells
- New 5?-reductase inhibitors: In vitro and in vivo effects
- The Role of Histone Demethylases in Disease
- METHOD DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC ESTIMATION OF FINASTERIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase